Free Trial

Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Fonar Corporation stock logo
FONR
Fonar
$14.88
+3.2%
$13.52
$12.00
$18.68
$89.45M0.9917,084 shs18,182 shs
NeuroPace, Inc. stock logo
NPCE
NeuroPace
$10.71
-2.1%
$12.84
$5.45
$18.98
$358.82M2.03184,422 shs2.29 million shs
Outset Medical, Inc. stock logo
OM
Outset Medical
$19.07
-5.3%
$16.96
$5.85
$72.60
$356.75M2.15144,913 shs2.99 million shs
Treace Medical Concepts, Inc. stock logo
TMCI
Treace Medical Concepts
$5.75
+2.9%
$6.30
$4.54
$10.79
$351.56M0.68529,189 shs503,379 shs
20 Stocks to Sell Now Cover

Today, we are inviting you to take a free peek at our proprietary, exclusive, and up-to-the-minute list of 20 stocks that Wall Street's top analysts hate.

Many of these appear to have good fundamentals and might seem like okay investments, but something is wrong. Analysts smell something seriously rotten about these companies. These are true "Strong Sell" stocks.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Fonar Corporation stock logo
FONR
Fonar
+3.19%+4.94%+3.69%+7.05%-7.58%
NeuroPace, Inc. stock logo
NPCE
NeuroPace
-2.10%+2.88%-14.04%-9.62%+56.35%
Outset Medical, Inc. stock logo
OM
Outset Medical
-5.27%+0.47%-2.21%+51.59%-68.53%
Treace Medical Concepts, Inc. stock logo
TMCI
Treace Medical Concepts
+2.86%+4.36%-1.71%-31.95%-8.59%
CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & Valuation
Fonar Corporation stock logo
FONR
Fonar
1.7355 of 5 stars
0.03.00.00.03.30.81.9
NeuroPace, Inc. stock logo
NPCE
NeuroPace
3.3636 of 5 stars
3.43.00.00.02.54.20.6
Outset Medical, Inc. stock logo
OM
Outset Medical
1.4672 of 5 stars
3.51.00.00.02.20.80.0
Treace Medical Concepts, Inc. stock logo
TMCI
Treace Medical Concepts
2.2175 of 5 stars
3.11.00.00.02.23.30.6
CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
Fonar Corporation stock logo
FONR
Fonar
0.00
N/AN/AN/A
NeuroPace, Inc. stock logo
NPCE
NeuroPace
2.83
Moderate Buy$15.5044.72% Upside
Outset Medical, Inc. stock logo
OM
Outset Medical
3.00
Buy$27.0041.58% Upside
Treace Medical Concepts, Inc. stock logo
TMCI
Treace Medical Concepts
2.29
Hold$10.1676.65% Upside

Current Analyst Ratings Breakdown

Latest FONR, TMCI, NPCE, and OM Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
5/28/2025
NeuroPace, Inc. stock logo
NPCE
NeuroPace
HC Wainwright
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Initiated CoverageBuy$18.00
5/21/2025
Outset Medical, Inc. stock logo
OM
Outset Medical
Royal Bank Of Canada
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingSector Perform ➝ Sector Perform$14.00 ➝ $21.00
5/15/2025
Outset Medical, Inc. stock logo
OM
Outset Medical
Scotiabank
Subscribe to MarketBeat All Access for the recommendation accuracy rating
UpgradeStrong-Buy
5/14/2025
NeuroPace, Inc. stock logo
NPCE
NeuroPace
JPMorgan Chase & Co.
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetOverweight ➝ Overweight$14.00 ➝ $16.00
5/14/2025
NeuroPace, Inc. stock logo
NPCE
NeuroPace
Cantor Fitzgerald
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingOverweight ➝ Overweight$17.00 ➝ $17.00
5/9/2025
Treace Medical Concepts, Inc. stock logo
TMCI
Treace Medical Concepts
UBS Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetNeutral ➝ Neutral$10.00 ➝ $8.60
5/8/2025
Outset Medical, Inc. stock logo
OM
Outset Medical
Royal Bank Of Canada
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetSector Perform ➝ Sector Perform$12.00 ➝ $14.00
4/11/2025
Treace Medical Concepts, Inc. stock logo
TMCI
Treace Medical Concepts
Truist Financial
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetHold ➝ Hold$9.50 ➝ $8.00
(Data available from 6/28/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)
CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
Fonar Corporation stock logo
FONR
Fonar
$102.88M0.90$3.17 per share4.69$24.78 per share0.60
NeuroPace, Inc. stock logo
NPCE
NeuroPace
$79.91M4.40N/AN/A$0.27 per share39.67
Outset Medical, Inc. stock logo
OM
Outset Medical
$113.69M2.97N/AN/A$7.49 per share2.55
Treace Medical Concepts, Inc. stock logo
TMCI
Treace Medical Concepts
$209.36M1.73N/AN/A$1.81 per share3.18
CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
Fonar Corporation stock logo
FONR
Fonar
$10.57M$1.2511.90N/A8.19%5.31%3.97%N/A
NeuroPace, Inc. stock logo
NPCE
NeuroPace
-$27.14M-$0.84N/AN/AN/A-29.42%-190.84%-25.08%8/12/2025 (Estimated)
Outset Medical, Inc. stock logo
OM
Outset Medical
-$127.98M-$29.15N/AN/A-98.74%-143.62%-37.50%8/6/2025 (Estimated)
Treace Medical Concepts, Inc. stock logo
TMCI
Treace Medical Concepts
-$55.74M-$0.85N/AN/AN/A-25.14%-48.69%-24.59%8/5/2025 (Estimated)

Latest FONR, TMCI, NPCE, and OM Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
5/15/2025Q3 2025
Fonar Corporation stock logo
FONR
Fonar
N/A$0.37N/A$0.37N/AN/A
5/13/2025Q1 2025
NeuroPace, Inc. stock logo
NPCE
NeuroPace
-$0.26-$0.21+$0.05-$0.21$21.85 million$22.52 million
5/8/2025Q1 2025
Treace Medical Concepts, Inc. stock logo
TMCI
Treace Medical Concepts
-$0.31-$0.25+$0.06-$0.25$52.07 million$52.57 million
5/7/2025Q1 2025
Outset Medical, Inc. stock logo
OM
Outset Medical
-$0.97-$3.66-$2.69-$3.66$27.81 million$29.75 million
CompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive Growth
Fonar Corporation stock logo
FONR
Fonar
N/AN/AN/AN/AN/A
NeuroPace, Inc. stock logo
NPCE
NeuroPace
N/AN/AN/AN/AN/A
Outset Medical, Inc. stock logo
OM
Outset Medical
N/AN/AN/AN/AN/A
Treace Medical Concepts, Inc. stock logo
TMCI
Treace Medical Concepts
N/AN/AN/AN/AN/A
CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
Fonar Corporation stock logo
FONR
Fonar
N/A
10.05
9.86
NeuroPace, Inc. stock logo
NPCE
NeuroPace
2.46
6.63
5.70
Outset Medical, Inc. stock logo
OM
Outset Medical
0.57
8.37
6.74
Treace Medical Concepts, Inc. stock logo
TMCI
Treace Medical Concepts
0.51
4.50
3.36

Institutional Ownership

CompanyInstitutional Ownership
Fonar Corporation stock logo
FONR
Fonar
50.64%
NeuroPace, Inc. stock logo
NPCE
NeuroPace
78.83%
Outset Medical, Inc. stock logo
OM
Outset Medical
N/A
Treace Medical Concepts, Inc. stock logo
TMCI
Treace Medical Concepts
84.08%

Insider Ownership

CompanyInsider Ownership
Fonar Corporation stock logo
FONR
Fonar
1.55%
NeuroPace, Inc. stock logo
NPCE
NeuroPace
20.50%
Outset Medical, Inc. stock logo
OM
Outset Medical
2.40%
Treace Medical Concepts, Inc. stock logo
TMCI
Treace Medical Concepts
27.72%
CompanyEmployeesShares OutstandingFree FloatOptionable
Fonar Corporation stock logo
FONR
Fonar
4806.20 million6.11 millionNot Optionable
NeuroPace, Inc. stock logo
NPCE
NeuroPace
17032.80 million26.08 millionOptionable
Outset Medical, Inc. stock logo
OM
Outset Medical
52017.72 million17.30 millionNot Optionable
Treace Medical Concepts, Inc. stock logo
TMCI
Treace Medical Concepts
25062.89 million45.46 millionOptionable

Recent News About These Companies

TMCI Treace Medical Concepts, Inc. - Seeking Alpha
Deadline Soon: Treace Medical Concepts, Inc. ...

New MarketBeat Followers Over Time

Media Sentiment Over Time

Fonar stock logo

Fonar NASDAQ:FONR

$14.88 +0.46 (+3.19%)
Closing price 06/27/2025 04:00 PM Eastern
Extended Trading
$14.82 -0.07 (-0.44%)
As of 06/27/2025 04:51 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

FONAR Corporation, together with its subsidiaries, engages in the research, development, production, and marketing of magnetic resonance imaging (MRI) scanners for the detection and diagnosis of human diseases in the United States. The company operates in two segments, Medical Equipment, and Physician Management and Diagnostic Services. It provides Upright MRI scanner that allows patients to be scanned in weight-bearing conditions, such as standing, sitting, bending, or lying down. The company also offers non-medical management, including administrative services, billing and collection services, credentialing services, contract negotiations, compliance consulting, purchasing IT services, hiring, conducting interviews, training, supervision and management of non-medical personnel, storage of medical records, office space, equipment, repair maintenance services, accounting, assistance with compliance matters, and development and implementation of practice growth and marketing strategies. It owns and operates diagnostic imaging facilities in Florida; and manages MRI scanning facilities. The company markets its scanners to private diagnostic imaging centers and hospital outpatient imaging facilities. FONAR Corporation was founded in 1970 and is based in Melville, New York.

NeuroPace stock logo

NeuroPace NASDAQ:NPCE

$10.71 -0.23 (-2.10%)
Closing price 06/27/2025 04:00 PM Eastern
Extended Trading
$10.70 -0.01 (-0.09%)
As of 06/27/2025 07:39 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

NeuroPace, Inc. operates as a medical device company in the United States. The company develops RNS system, a brain-responsive neuromodulation system that delivers personalized, real-time treatment at the seizure source for treating medically refractory focal epilepsy. It also records continuous brain activity data and enables clinicians to monitor patients in person and remotely. Its RNS System includes RNS neurostimulator, cortical strip and depth leads, and Patient Remote Monitor, as well as other implantable and non-implantable accessories. The company sells its products to hospital facilities for initial RNS system implant procedures and for replacement procedures. NeuroPace, Inc. was incorporated in 1997 and is headquartered in Mountain View, California.

Outset Medical stock logo

Outset Medical NASDAQ:OM

$19.07 -1.06 (-5.27%)
Closing price 06/27/2025 04:00 PM Eastern
Extended Trading
$18.86 -0.21 (-1.07%)
As of 06/27/2025 06:35 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Outset Medical, Inc., a medical technology company, engages in the development of a hemodialysis system for hemodialysis in the United States. The company offers Tablo Hemodialysis System, a compact console with integrated water purification, on-demand dialysate production, and software and connectivity capabilities for dialysis care in acute and home settings; and manufactures, supports, and distributes for Tablo console, Tablo cartridge, and other consumables. It also provides Tablo Data Ecosystem, including TabloHub, a customer-facing portal; MyTablo, a patient-facing portal; and TabloDash, an internal data analytics platform. The company was formerly known as Home Dialysis Plus, Ltd. and changed its name to Outset Medical, Inc. in January 2015. Outset Medical, Inc. was incorporated in 2003 and is headquartered in San Jose, California.

Treace Medical Concepts stock logo

Treace Medical Concepts NASDAQ:TMCI

$5.75 +0.16 (+2.86%)
Closing price 06/27/2025 04:00 PM Eastern
Extended Trading
$5.56 -0.20 (-3.39%)
As of 06/27/2025 04:36 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Treace Medical Concepts, Inc., a medical technology company, designs, manufactures, and markets medical devices in the United States. The company offers Lapiplasty 3D bunion correction system that combines instruments, implants, and surgical methods designed to surgically correct three planes of the bunion deformity. It also provides Lapiplasty mini-incision system designed to allow the Lapiplasty procedure to be performed through a 3.5cm incision. In addition, the company offers Adductoplasty system designed for reproducible realignment, stabilization, and fusion of the midfoot. Treace Medical Concepts, Inc. was founded in 2013 and is headquartered in Ponte Vedra, Florida.